GenBody Rapid
COVID-19 Ag Test
Authorized for point-of-care use. Shallow nasal swabs for comfort.
Make An InquiryContact Us
If you would like to place an order, please fill out the information below or call us at 949-561-0664
How to Order
If you would like to place an order or contact us, please fill out the information below or call us at 949-561-0664
GenBody COVID-19 Ag Packaging Configurations
GenBody Product
Kit Box
Dimension
9.84 X 4.92 X 3.54 inch
Weight
0.77 lbs / Kit
Package
25 Tests/ Kits
Carton Box
Dimension
22.44 X 15.35 X 20.47 inch
Weight
35.05 lbs / Carton
Package
36 Kits / Carton
Pallet
Dimension
48 X 40 X 68 inch
Weight
420.64 lbs / Pallet
Package
12 Cartons / Pallet
GenBody COVID-19 Ag packaged with NP swap
Cat No.
COVAG025-U
Product Name
GenBody COVID-19 Ag packaged with nasal swap
Package
25 tests / Kit
Kit Box Size (inch)
9.84 X 4.92 X 3.54
Carton Size (inch)
22.44 X 15.35 X 20.47
GenBody COVID-19 Ag packaged with NP swap
Cat No.
COVAG025-NU
Product Name
GenBody COVID-19 Ag packaged with nasal swap
Package
25 tests / Kit
Kit Box Size (inch)
9.84 X 4.92 X 3.54
Carton Size (inch)
22.44 X 15.35 X 20.47
GenBody Product
GenBody COVID-19 Ag
Kit Box
Dimension
Weight
Package
9.84 X 4.92 X 3.54 inch
0.77 lbs / Kit
25 Tests/ Kits
Carton Box
Dimension
Weight
Package
22.44 X 15.35 X 20.47 inch
35.05 lbs / Carton
36 Kits / Carton
Pallet
Dimension
Weight
Package
48 X 40 X 68 inch
420.64 lbs / Pallet
12 Cartons / Pallet
Cat No.
Product Name
Package
Kit Box Size (inch)
Carton Size (inch)
COVAG025-U
GenBody COVID-19 Ag packaged with nasal swap
25 tests / Kit
9.84 X 4.92 X 3.54
22.44 X 15.35 X 20.47
COVAG025-NU
GenBody COVID-19 Ag packaged with nasal swap
25 tests / Kit
9.84 X 4.92 X 3.54
22.44 X 15.35 X 20.47
The GenBody COVID-19 Ag test has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories. The product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.